Unbiased AI-powered news
1 stories related to this topic, newest first.
Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…